Option Care Health, Inc. (NASDAQ:OPCH) Given Average Rating of "Moderate Buy" by Brokerages
Option Care Health, Inc. (NASDAQ:OPCH - Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the fourteen analysts that are covering the company, Marketbeat. com reports. Seven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to
Option Care Health, Inc. (NASDAQ:OPCH-Get Free Report) has been assigned a consensus rating of "Moderate Buy" from the fourteen analysts that are covering the company,Marketbeat. comreports. Seven research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $29. 9231. Option Care Health Stock is Making a Healthy PullbackSeveral research analysts have recently weighed in on OPCH shares. TD Cowen lowered their price objective on shares of Option Care Health from $37. 00 to $23. 00 and set a "hold" rating on the stock in a research note on Friday, May 1st. UBS Group reiterated a "buy" rating on shares of Option Care Health in a research note on Tuesday, June 16th. Stephens reiterated an "equal weight" rating and set a $24. 00 price target (down from $30. 00) on shares of Option Care Health in a report on Friday, July 17th. Barrington Research lowered their price target on Option Care Health from $42. 00 to $32. 00 and set an "outperform" rating on the stock in a research report on Friday, May 1st. Finally, Bank of America lowered Option Care Health from a "buy" rating to a "neutral" rating and set a $22. 00 price objective on the stock. in a research note on Friday, May 1st. GetOption Care Healthalerts:Read Our Latest Stock Analysis on OPCHOption Care Health Price PerformanceNASDAQ:OPCHopened at $23. 94 on Friday. The stock has a market capitalization of $3. 59 billion, a PE ratio of 18. 00, a P/E/G ratio of 1. 39 and a beta of 0. 65. Option Care Health has a 1-year low of $18. 01 and a 1-year high of $36. 80. The firm has a fifty day simple moving average of $22. 10 and a 200 day simple moving average of $25. 98. The company has a current ratio of 1. 47, a quick ratio of 0. 98 and a debt-to-equity ratio of 0. 91. Option Care Health (NASDAQ:OPCH-Get Free Report) last posted its quarterly earnings results on Wednesday, July 29th. The company reported $0. 45 earnings per share (EPS) for the quarter, topping the consensus estimate of $0. 43 by $0. 02. The firm had revenue of $1. 44 billion for the quarter, compared to analyst estimates of $1. 42 billion. Option Care Health had a net margin of 3. 68% and a return on equity of 18. 74%. The company's quarterly revenue was up 1. 9% compared to the same quarter last year. During the same period in the prior year, the firm posted $0. 41 earnings per share. Option Care Health has set its FY 2026 guidance at 1. 850-1. 920 EPS. On average, research analysts expect that Option Care Health will post 1. 69 EPS for the current fiscal year. Institutional Inflows and OutflowsA number of institutional investors have recently made changes to their positions in the business. Advisory Services Network LLC bought a new stake in Option Care Health in the 3rd quarter valued at $35,000. McIlrath & Eck LLC bought a new position in Option Care Health during the second quarter worth $37,000. Caitong International Asset Management Co. Ltd bought a new position in Option Care Health during the third quarter worth $38,000. Quarry LP increased its holdings in shares of Option Care Health by 502. 7% in the third quarter. Quarry LP now owns 1,549 shares of the company's stock valued at $43,000 after purchasing an additional 1,292 shares during the last quarter. Finally, Employees Retirement System of Texas acquired a new position in shares of Option Care Health in the fourth quarter valued at $45,000. 98. 05% of the stock is owned by institutional investors and hedge funds. Option Care Health Company Profile(Get Free Report)Option Care HealthNASDAQ: OPCHis a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting. Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry's most experienced home infusion businesses. Further ReadingFive stocks we like better than Option Care HealthIs Best Buy the AI Winner Hiding in the Electronics Aisle?Applied Materials Beat Everything but Wall Street’s Expectations for MarginsBack From Orbit, Intuitive Machines' Share Price Enters the Buy ZoneTexas Roadhouse and Brinker International Have the Recipe Rivals Are MissingThis instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat. com. Continue following MarketBeatAdd MarketBeat as your preferred source on Google to see our latest stories in your feed. Should You Invest $1,000 in Option Care Health Right Now?Before you consider Option Care Health, you'll want to hear this. MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified thefive stocksthat top analysts are quietly whispering to their clients to buy now before the broader market catches on. . . and Option Care Health wasn't on the list. While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys. View The Five Stocks HereTesla, Nvidia, and Google helped shape the last era of market growth, but the next wave could come from a new group of companies. Inside this report, you’ll find 7 stocks that could play a major role in the next tech-driven market boom. Get This Free Report